tiprankstipranks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market

Citius Oncology (CTOR) Income Statement

Compare
63 Followers

Citius Oncology Income Statement

Last quarter (Q1 2025), Citius Oncology's total revenue was $0.00, a decrease of ― from previous quarter. In Q1, Citius Oncology's net income was $-6.66M. See Citius Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 20.57M$ 12.12M$ 4.86M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00
EBITDA
$ -20.57M$ -12.12M$ -4.86M
Operating Income
$ -20.57M$ -12.12M$ -4.86M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00
Pretax Income
$ -20.57M$ -12.12M$ -4.86M
Net Income
$ -21.15M$ -12.70M$ -5.43M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -0.30$ 0.00$ 0.04
Diluted EPS
$ -0.30$ 0.00$ 0.04
Weighted Average Shares Outstanding
71.55M 0.00 9.02M
Weighted Average Shares Outstanding (Diluted)
71.55M 0.00 9.02M
Currency in USD

Citius Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis